Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
MOUNJARO tirzepatide 7.5 mg/0.5 mL solution for injection vial, Eli Lilly Australia Pty Ltd, CON-1146
Product name
MOUNJARO tirzepatide 7.5 mg/0.5 mL solution for injection vial
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1146
Standard
Paragraph 8(3)(d), Paragraph 8(3)(e), Paragraph 10(5)(e), Paragraph 10(5)(f). of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not conform as the labels for both the carton and vial have the
batch number and expiry date prefix above the information rather than preceding
it.
Therapeutic product type
Prescription medicines